Immunome Promotes Max Rosett To CFO, Effective May 9
Portfolio Pulse from Benzinga Newsdesk
Immunome has promoted Max Rosett to Chief Financial Officer, effective May 9. Rosett previously served as Executive Vice President, Operations, and Interim CFO since January 2024.
May 17, 2024 | 12:05 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Immunome has promoted Max Rosett to Chief Financial Officer, effective May 9. Rosett has been with the company as EVP, Operations, and Interim CFO since January 2024.
The promotion of Max Rosett to CFO is likely to be viewed positively by investors as it provides stability and continuity in the company's financial leadership. Rosett's prior experience as EVP, Operations, and Interim CFO suggests he is well-versed in the company's operations and financial strategies.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100